⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S8 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression

Jordan L. Kohlmeyer Joshua J. Lingo Courtney A. Kaemmer Amanda Scherer Akshaya Warrier Ellen Voigt Juan A. Raygoza Garay Gavin R. McGivney Qierra R. Brockman Amy Tang Ana Calizo Kai Pollard Xiaochun Zhang Angela C. Hirbe Christine A. Pratilas Mariah Leidinger Patrick Breheny Michael S. Chimenti Jessica C. Sieren Varun Monga Munir R. Tanas David K. Meyerholz Benjamin W. Darbro Rebecca D. Dodd Dawn E. Quelle

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure S8. Additional MPNST analyses for CDK4/6-MEK inhibition plus anti-PD-L1 therapy study.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kohlmeyer et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db6435875226e1 https://doi.org/10.1158/1078-0432.27032902

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S8 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
2Supplementary Figure S6 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
3Supplementary Figure S6 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
4Supplementary Figure S1 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
5Supplementary Figure S1 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024

Supplementary Figure S3 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
Supplementary Figure S3 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024
Supplementary Figure S7 from CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression2024